IPXL

Impax Laboratories, Inc. News Headlines

$24.65
*  
0.12
0.49%
Get IPXL Alerts
*Delayed - data as of Aug. 28, 2014  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare
4/11/2014 8:15:08 AM - MT Newswires

Pacira and Patheon Collaborate - Analyst Blog
4/8/2014 6:10:01 PM - Zacks.com

Additional Data on Pacira's Exparel - Analyst Blog
4/8/2014 5:20:01 PM - Zacks.com

Actavis Up Slightly on Silom Acquisition - Analyst Blog
4/3/2014 3:56:01 PM - Zacks.com

Millennium Management buys a position in Endo International
3/24/2014 6:58:00 PM - Market Realist

How Impax Laboratories (IPXL) Stock Stands Out in a Strong Industry - Tale of the Tape
3/14/2014 8:20:01 AM - Zacks.com

Narrower-than-Expected Loss at Supernus - Analyst Blog
3/13/2014 9:40:01 AM - Zacks.com

Pernix to Market Osmotica's Khedezla - Analyst Blog
3/3/2014 6:30:01 PM - Zacks.com

Patent Update from Mallinckrodt - Analyst Blog
2/27/2014 6:20:01 PM - Zacks.com

Legal Settlement at Endo on Lidoderm - Analyst Blog
2/24/2014 12:30:01 PM - Zacks.com

Impax Posts Loss in 4Q - Analyst Blog
2/21/2014 12:27:01 PM - Zacks.com

Market-Makers' Best Equity Bets On Presidents' Day, 2014
2/17/2014 5:06:00 AM - Seeking Alpha

Another Divestment at Actavis - Analyst Blog
1/28/2014 5:45:01 PM - Zacks.com

Allergan Slips on Restasis Challenge - Analyst Blog
1/23/2014 2:50:01 PM - Zacks.com

Mallinckrodt Up on FDA Approval - Analyst Blog
1/21/2014 1:10:01 PM - Zacks.com

Impax's Outlook for 2014 - Analyst Blog
1/16/2014 8:15:01 PM - Zacks.com

FDA Panel Backs CHTP's Northera - Analyst Blog
1/15/2014 7:10:01 PM - Zacks.com

Actavis Discusses Preliminary Q4 Results - Analyst Blog
1/15/2014 5:53:01 PM - Zacks.com

Mallinckrodt, Zogenix to End Deal - Analyst Blog
1/10/2014 7:40:01 PM - Zacks.com

A New CEO for Teva - Analyst Blog
1/10/2014 5:45:01 PM - Zacks.com

Expected Decision In Avanir Nuedexta Patent Litigation
1/8/2014 1:14:00 PM - Seeking Alpha

India - An important Market for Mylan - Analyst Blog
1/6/2014 12:40:01 PM - Zacks.com

Zacks' Bear Of The Day: Magellan Health Services
12/30/2013 1:40:00 PM - Seeking Alpha

Bear of the Day: Magellan Health Services (MGLN) - Bear of the Day
12/30/2013 5:16:01 AM - Zacks.com

Bear of the Day: Magellan Health Services (MGLN) - Bear of the Day
12/30/2013 4:16:00 AM - Investopedia